DrugPatentWatch Database Preview
Drugs in Development Information for Masitinib
Email this page to a colleague
What is the drug development status for Masitinib?
Masitinib is an investigational drug.
There have been 32 clinical trials for Masitinib.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2011.
The most common disease conditions in clinical trials are Gastrointestinal Stromal Tumors, Mastocytosis, and Sclerosis. The leading clinical trial sponsors are AB Science and [disabled in preview].
Summary for Masitinib
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 718 |
| WIPO Patent Applications | 587 |
| Japanese Patent Applications | 223 |
| Clinical Trial Progress | Phase 2 (2011-06-01) |
| Vendors | 80 |
Recent Clinical Trials for Masitinib
| Title | Sponsor | Phase |
|---|---|---|
| Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 | AB Science | Phase 2 |
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment | AB Science | Phase 3 |
| Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients | AB Science | Phase 3 |
Clinical Trial Summary for Masitinib
Top disease conditions for Masitinib
Top clinical trial sponsors for Masitinib
US Patents for Masitinib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
